(S1 (S (NP (-LRB- -LSB-) (NP (NP (NP (JJ Autologous) (NN bone) (NN marrow)) (NN stem) (NN cell)) (CC or) (NP (NP (JJ peripheral) (NN blood) (JJ endothelial) (NN progenitor) (NN cell)) (NN therapy))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ peripheral) (NN limb) (NN ischaemia))))) (-RRB- -RSB-))))
(S1 (S (S (NP (DT No) (JJ effective) (JJ medical) (NNS therapies)) (VP (VBP have) (VP (VBN been) (VP (VBN developed) (NP (NN sofar)) (S (VP (TO to) (VP (VB enhance) (NP (NN blood) (NN flow)) (PP (IN in) (NP (NP (DT the) (NNS legs)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (JJ peripheral) (JJ arterial) (NN disease)) (PRN (-LRB- -LRB-) (NP (NN PAD)) (-RRB- -RRB-))))))))))))))) (. .)))
(S1 (S (S (PP (IN For) (NP (NP (NNS patients)) (PP (IN with) (NP (NN limb) (NN threatening) (NN ischaemia))))) (NP (NP (DT the) (JJ only) (NN option)) (PP (IN for) (NP (NP (NN relief)) (PP (IN of) (NP (NN rest) (NP (NN pain)) (CC or) (NP (NN gangraena))))))) (VP (VBZ is) (NP (NN amputation)))) (. .)))
(S1 (S (S (NP (EX There)) (VP (VBZ is) (NP (NP (NN evidence)) (PP (IN in) (NP (NP (ADJP (ADJP (JJ experimental)) (CC and) (ADJP (JJ clinical))) (NNS studies)) (SBAR (WHNP (WDT that)) (S (NP (NP (JJ adult) (NN bone) (JJ marrow-derived) (NN stem) (NNS cells)) (CC and) (NP (JJ endothelial) (NN progenitor) (NNS cells))) (VP (VBP participate) (PP (IN in) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NP (JJ new) (NN blood) (NNS vessels)) (, ,) (VP (VBN called) (S (NP (NP (NN neoangiogenesis)) (CC or) (NP (NN neovascularization))))))))))))))))) (. .)))
(S1 (S (S (NP (NP (JJ Clinical) (NNS results)) (VP (VBN induced) (PP (IN by) (NP (JJ autologous) (NN bone) (NN marrow) (NP (NN stem) (NNS cells)) (CC or) (NP (JJ angiogenic) (NN growth/differentiation) (NNS factors)))) (PP (IN in) (NP (NP (JJ end-stage) (NNS patients)) (PP (IN with) (NP (NN PAD))))))) (VP (VBP are) (VP (VBN summarized)))) (. .)))
(S1 (S (S (S (VP (VBG Considering) (NP (NP (DT the) (ADJP (RB relatively) (JJ few)) (NN number)) (PP (IN of) (NP (NP (NNS patients)) (VP (VBN treated) (PP (IN by) (NP (JJ angiogenic) (NN therapy))))))))) (, ,) (NP (NP (DT the) (NN interpretation)) (PP (IN of) (NP (JJ clinical) (NNS results)))) (VP (VBZ needs) (NP (NN cautiousness)))) (. .)))
